Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4

Blood

Volumn 97, Issue 11, 2001, Pages 3484-3490

  Li, Yong ^a,b,c,d   Li, Xin ^a,b,c,d   Wadley, Robert ^a,b,c,d   Reddel, Stephen W ^a,b,c,d   Qi, Jian C ^a,b,c,d   Archis, Con ^a,b,c,d   Collins, Andrew ^a,b,c,d   Clark, Elizabeth ^a,b,c,d   Cooley, Margaret ^a,b,c,d   Kouts, Steven ^a,b,c,d   Naif, Hassan M ^a,b,c,d   Alali, Mohammed ^a,b,c,d   Cunningham, Anthony ^a,b,c,d   Wong, Guang W ^a,b,c,d   Stevens, Richard L ^a,b,c,d   Krilis, Steven A ^a,b,c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN E RECEPTOR;

ALLERGY; ARTICLE; BASOPHIL; BLOOD; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MAST CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0035383817     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3484     Document Type: Article

References (59)

1. Metzger H, Kinet JP, Blank U, Miller L, Ra C. The receptor with high affinity for IgE. Ciba Found Symp. 1989;147:93-101.
2. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993;328:257-265.
3. Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells: purification and characterization. J Biol Chem. 1981;256:11939-11943.
4. Meier HL, Heck LW, Schulman ES, MacGlashan DW Jr. Purified human mast cells and basophils release human elastase and cathepsin G by an IgE-mediated mechanism. Int Arch Allergy Appl Immunol. 1985;77:179-183.
5. Goldstein SM, Kaempfer CE, Kealey JT, Wintroub BU. Human mast cell carboxypeptidase: purification and characterization. J Clin Invest. 1989;83:1630-1636.
6. Reynolds DS, Gurley DS, Stevens RL, Sugarbaker DJ, Austen KF, Serafin WE. Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. Proc Natl Acad Sci U S A. 1989;86:9480-9484.
7. Miller JS, Westin EH, Schwartz LB. Cloning and characterization of complementary DNA for human tryptase. J Clin Invest. 1989;84:1188-1195.
8. Miller JS, Moxley G, Schwartz LB. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest. 1990;86:864-870.
9. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A. 1990;87:3811-3815.
10. TC type of human mast cell. J Immunol. 1990;145:2652-2661.
11. Caughey GH, Zerweck EH, Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem. 1991;266:12956-12963.
12. Urata H, Kinoshita A, Perez DM, et al. Cloning of the gene and cDNA for human heart chymase. J Biol Chem. 1991;266:17173-17179.
13. Wong GW, Tang Y, Feyfant E, et al. Identification of a new member of the tryptase family of mouse and human mast cell proteases that possesses a novel COOH-terminal hydrophobic extension. J Biol Chem. 1999;274:30784-30793.
14. TC cells. J Immunol. 1991;147:247-253.
15. Xia HZ, Kepley CL, Sakai K, Chelliah J, Irani AM, Schwartz LB. Quantitation of tryptase, chymase, FcεRIα, and FcεRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol. 1995;154:5472-5480.
16. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987;138:2184-2189.
17. Padawer J. Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions. Exp Mol Pathol. 1974;20:269-280.
18. v mice: evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med. 1985;162:1025-1043.
19. Levi-Schaffer F, Austen KF, Gravallese PM, Stevens RL. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci U S A. 1986;83:6485-6488.
20. Gurish MF, Ghildyal N, McNeil HP, Austen KF, Gillis S, Stevens RL. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med. 1992;175:1003-1012.
21. Ghildyal N, Friend DS, Nicodemus CF, Austen KF, Stevens RL. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol. 1993;151:3206-3214.
22. Gurish MF, Pear WS, Stevens RL, et al. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. Immunity. 1995;3:175-186.
23. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol. 1996;135:279-290.
24. Friend DS, Ghildyal N, Gurish MF, et al. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis. J Immunol. 1998;160:5537-5545.
25. Lee YM, Jippo T, Kim DK, et al. Alteration of protease expression phenotype of mouse peritoneal mast cells by changing the microenvironment as demonstrated by in situ hybridization histochemistry. Am J Pathol. 1998;153:931-936.
26. Longley BJ, Tyrrell L, Lu S, Ma Y, Klump V, Murphy GF. Chronically c-kit-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments. J Invest Dermatol. 1997;108:792-796.
27. Friend DS, Gurish MF, Austen KF, Hunt J, Stevens RL. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J Immunol. 2000;165:344-352.
28. Li L, Li Y, Reddel SW, et al. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J Immunol. 1998;161:5079-5086.
29. Uguccioni M, Mackay CR, Ochensberger B, et al. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 1997;100:1137-1143.
30. Jinquan T, Jacobi HH, Jing C, et al. Chemokine stromal cell-derived factor 1α activates basophils by means of CXCR4. J Allergy Clin Immunol. 2000;106:313-320.
31. Kinet JP, Metzger H, Hakimi J, Kochan J. A cDNA presumptively coding for the α subunit of the receptor with high affinity for immunoglobulin E. Biochemistry. 1987;26:4605-4610.
32. Li L, Meng XW, Krilis SA. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. J Immunol. 1996;156:4839-4844.
33. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol. 1998;72:830-836.
34. Foster B, Schwartz LB, Metcalfe DD, Prussin C. Tryptase is expressed by human basophils independent of disease status [abstract]. J Allergy Clin Immunol. 2000;105:S89.
35. Romagnani P, De Paulis A, Beltrame C, et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol. 1999;155:1195-1204.
36. Lin TJ, Issekutz TB, Marshall JS. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1α. J Immunol. 2000;165:211-220.
37. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999;190:267-280.
38. Ledbetter JA, Evans RL, Lipinski M, et al. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med. 1981;153:310-323.
39. + hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood. 1994;84:1896-1905.
40. + bone marrow progenitor cells. J Immunol. 1991;146:1410-1415.
41. Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA. 1997;278:1815-1822.
42. Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE, Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med. 1993;178:1079-1084.
43. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984;312:763-767.
44. D'Souza MP, Harden VA. Chemokines and HIV-1 second receptors: confluence of two fields generates optimism in AIDS research. Nat Med. 1996;2:1293-1300.
45. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872-877.
46. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829-833.
47. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
48. + T cells. Science. 1995;270:1811-1815.
49. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667-673.
50. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996;85:1149-1158.
51. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955-1958.
52. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135-1148.
53. Reynolds DS, Serafin WE, Faller DV, et al. Immortalization of murine connective tissue-type mast cells at multiple stages of their differentiation by coculture of splenocytes with fibroblasts that produce Kirsten sarcoma virus. J Biol Chem. 1988;263:12783-12791.
54. Valent P, Ashman LK, Hinterberger W, et al. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood. 1989;73:1778-1785.
55. Lee B, Ratajczak J, Doms RW, Gewirtz AM, Ratajczak MZ. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. Blood. 1999;93:1145-1156.
56. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5:512-517.
57. Carpenter CC, Fischl MA, Hammer SM, et al. Anti-retroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998;280:78-86.
58. - mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol. 1987;138:4381-4386.
59. Weller PF, Marshall WL, Lucey DR, Rand TH, Dvorak AM, Finberg RW. Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1. Am J Respir Cell Mol Biol. 1995;13:610-620.